Effectiveness and safety of reduced and standard daily doses of direct oral anticoagulants in patients with nonvalvular atrial fibrillation: A cohort study using national …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - Taylor & Francis
Purpose To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
[HTML][HTML] Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - ncbi.nlm.nih.gov
Purpose To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
[引用][C] Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - cir.nii.ac.jp
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in
Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database …
Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database …
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - dovepress.com
Purpose: To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using …
K Kubota, N Ooba - Clinical epidemiology, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - europepmc.org
Purpose To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using …
K Kubota, N Ooba - Clinical Epidemiology, 2022 - dovepress.com
Purpose: To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …